<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01812031</url>
  </required_header>
  <id_info>
    <org_study_id>AOL09-PR-MEYER</org_study_id>
    <secondary_id>2009-A00491-56</secondary_id>
    <nct_id>NCT01812031</nct_id>
  </id_info>
  <brief_title>Benefits Study of Respiratory-gated PET Acquisition in Lung Disease</brief_title>
  <acronym>PneumoTEP</acronym>
  <official_title>Benefits Study of a Respiratory Gating Protocol for Positron Emission Tomography: Application on the Lungs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fluorodeoxyglucose (FDG) positron emission tomography (PET) is now widely used for cancer&#xD;
      imaging purpose, notably for preoperative work-up. It aims at visualizing organs metabolism.&#xD;
      In case of cancer, metabolism is, classically, increased and some hot spots are visible on&#xD;
      PET images. Because of respiratory motion some lung tumours (especially the smallest ones)&#xD;
      can be falsely interpreted by the clinician.&#xD;
&#xD;
      The investigators developed a respiratory-gated PET method in order to reduce the motion&#xD;
      issue. The investigators designed a study to investigate its effect on lung cancer (primary&#xD;
      or metastasis) to check if it improves the sensitivity/specificity of PET imaging of the&#xD;
      lungs.&#xD;
&#xD;
      To that aim, patients presenting a lung nodule on a CT examination can be proposed to&#xD;
      participate this study. After the standard PET acquisition (acquired in free-breathing), an&#xD;
      additional 10 minutes respiratory-gated PET acquisition is performed without additional&#xD;
      injection. After that, a breath-hold (~10s) CT is performed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lesion SUVmax</measure>
    <time_frame>Day 1</time_frame>
    <description>For each CT nodule, observer has to report the corresponding (maximum Standardized Uptake Value)SUVmax on ungated and CT-based images (even if there is no obvious uptake)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lung function test</measure>
    <time_frame>Day 0</time_frame>
    <description>Patients undergo lung function test including measures of:&#xD;
total lung capacity&#xD;
residual volume&#xD;
forced expiratory volume&#xD;
forced vital capacity</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">103</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Non Small Cell Lung Cancer</condition>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Lung nodules</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>&quot;Medical imaging&quot; intervention applied on patients included in the trial</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>medical imaging</intervention_name>
    <description>After fasting for at least 6 hours, normal glucose blood level was checked and each patient received an intravenous injection of 18F-FDG (5MBq/kg). After a 60-minute uptake phase in a quiet environment, patients underwent the PET/CT examination.&#xD;
Whole-body PET/CT (Ungated session) The Ungated acquisition consisted in a whole-body, free-breathing CT followed by standard multistep PET, used as routine clinical practice in the department.&#xD;
Respiratory-gated PET/CT (CT-based session) The CT-based method consisted in an additional single-step, 10-minute List Mode respiratory gated PET acquisition followed by an end-expiration breath-hold CT added to the end of the clinical protocol, with continuous respiratory signal recording during these examinations.</description>
    <arm_group_label>Lung nodules</arm_group_label>
    <other_name>Biograph</other_name>
    <other_name>Siemens medical solutions</other_name>
    <other_name>Anzai medical</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient has one or more lung lesion(s) less than 35 mm visible on a CT image&#xD;
&#xD;
          -  age : over 18 years&#xD;
&#xD;
          -  patients gave their written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  patient has at least one lesion more than 35 mm in its great axis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc-Etienne MEYER, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <state>Picardie</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Daouk J, Leloire M, Fin L, Bailly P, Morvan J, El Esper I, Saidi L, Moullart V, Fran√ßois G, Jounieaux V, Meyer ME. Respiratory-gated 18F-FDG PET imaging in lung cancer: effects on sensitivity and specificity. Acta Radiol. 2011 Jul 1;52(6):651-7. doi: 10.1258/ar.2011.110018. Epub 2011 Apr 21.</citation>
    <PMID>21511870</PMID>
  </results_reference>
  <results_reference>
    <citation>Daouk J, Bailly P, Kamimura M, Sacksick D, Jounieaux V, Meyer ME. Positron emission tomography-based evidence of low-amplitude respiratory motion in patients with chronic obstructive pulmonary disease. Ann Nucl Med. 2015 May;29(4):319-24. doi: 10.1007/s12149-014-0945-3. Epub 2015 Jan 8.</citation>
    <PMID>25567204</PMID>
  </results_reference>
  <verification_date>February 2015</verification_date>
  <study_first_submitted>March 13, 2013</study_first_submitted>
  <study_first_submitted_qc>March 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2013</study_first_posted>
  <last_update_submitted>February 26, 2015</last_update_submitted>
  <last_update_submitted_qc>February 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PET/CT</keyword>
  <keyword>18F-fluoro-2-deoxyglucose</keyword>
  <keyword>lung neoplasms</keyword>
  <keyword>respiratory motion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

